A detailed history of Arcadia Investment Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arcadia Investment Management Corp holds 25,001 shares of BMY stock, worth $1.47 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
25,001
Previous 24,571 1.75%
Holding current value
$1.47 Million
Previous $1.02 Million 26.76%
% of portfolio
0.21%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $17,053 - $22,252
430 Added 1.75%
25,001 $1.29 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $647,220 - $852,079
16,080 Added 189.38%
24,571 $1.02 Million
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $1.47 Million - $1.67 Million
-30,637 Reduced 78.3%
8,491 $460,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $3.43 Million - $4.09 Million
-70,782 Reduced 64.4%
39,128 $2.01 Million
Q3 2023

Oct 23, 2023

BUY
$57.89 - $64.73 $60,958 - $68,160
1,053 Added 0.97%
109,910 $6.38 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $174,119 - $193,332
-2,733 Reduced 2.45%
108,857 $6.96 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $689,297 - $781,819
10,490 Added 10.38%
111,590 $7.73 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $1.31 Million - $1.55 Million
-19,170 Reduced 15.94%
101,100 $7.27 Million
Q3 2022

Oct 19, 2022

SELL
$0.13 - $76.84 $186 - $110,034
-1,432 Reduced 1.18%
120,270 $8.55 Million
Q2 2022

Jul 21, 2022

BUY
$72.62 - $79.98 $228,898 - $252,096
3,152 Added 2.66%
121,702 $9.37 Million
Q1 2022

Apr 28, 2022

SELL
$61.48 - $73.72 $897,915 - $1.08 Million
-14,605 Reduced 10.97%
118,550 $8.66 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $340,604 - $397,064
-6,351 Reduced 4.55%
133,155 $8.3 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $24,378 - $28,555
412 Added 0.3%
139,506 $8.26 Million
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $395,047 - $430,207
6,381 Added 4.81%
139,094 $9.29 Million
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $1.93 Million - $2.17 Million
32,472 Added 32.39%
132,713 $8.38 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $616,951 - $699,119
10,685 Added 11.93%
100,241 $6.22 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $367,379 - $407,105
6,397 Added 7.69%
89,556 $5.4 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $3.81 Million - $5.54 Million
82,159 Added 8215.9%
83,159 $4.64 Million
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $55,230 - $63,740
1,000
1,000 $64,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.